Share the post "Genomic Valley Biotech Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results offer insight into the distribution of shares among various investors, highlighting the levels of institutional and retail ownership. These results are significant for analyzing investor confidence and market sentiment. Understanding shareholding patterns can aid stakeholders in predicting how changes in ownership might affect a company’s stock performance. Genomic Valley Biotech has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
---|---|---|---|---|---|
Promoters | 16.70 Lakh | 14.30 Lakh | 54.67 | 46.83 | -7.84 % |
Public | 13.85 Lakh | 16.24 Lakh | 45.33 | 53.17 | +7.84 % |
DII | 0 | 0 | 0 | 0 | 0 |
FII | 0 | 0 | 0 | 0 | 0 |
Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 54.67% in September 2024- to 46.83% in December 2024-. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 45.33% in September 2024-2025 to 53.17% in December 2024-2025.This change suggests that the public’s investment in the company grew during the quarter.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Below is a detailed table presenting the shareholding percentage of Promoters.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
Yogesh Agrawal | 15.49 Lakh | 14.28 Lakh | 50.7 | 46.76 | -3.94 % |
Parul Agrawal | 1.19 Lakh | 0 | 3.91 | 0 | -3.91 % |
Yogesh Agrawal faced a downturn in stakeholding this quarter, witnessing a decline of -3.94 % in stakeholding compared to the previous quarter.Parul Agrawal faced a downturn in stakeholding this quarter, witnessing a decline of -3.91 % in stakeholding compared to the previous quarter.
Below is a detailed table showcasing the public shareholding percentage.
Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 6.22 Lakh | 7.03 Lakh | 20.38 | 23.01 | + 2.63 % |
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 7.44 Lakh | 9.03 Lakh | 24.36 | 29.57 | + 5.21 % |
Vikram Ashokkumar Jain | 0 | 1.68 Lakh | 0 | 5.5 | +5.5% |
Purushothaman Shaji | 0 | 77.17 K | 0 | 2.53 | +2.53% |
Bodies Corporate | 1.01 K | 450 | 0.03 | 0.01 | -0.02 % |
Any Other (specify) | 13.68 K | 13.96 K | 0.45 | 0.46 | + 0.01 % |
HUF | 13.68 K | 13.96 K | 0.45 | 0.46 | + 0.01 % |
Harish Chandra Sharma | 87.65 K | 0 | 2.87 | 0 | -2.87% |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 2.63 %.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 5.21 %.Observations show a significant difference of -0.02 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.01 %.Vikram Ashokkumar Jain had no shares in the previous quarter but now holds 5.5% of shares in the current quarter.Purushothaman Shaji had no shares in the previous quarter but now holds 2.53% of shares in the current quarter.Harish Chandra Sharma had 2.87% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Genomic Valley Biotech”]